Artikkelit, joihin on yleisen käytön mandaatti - Antonio CraxiLisätietoja
Ei saatavilla missään: 6
Arvostele
Sarcopenia is associated with severe liver fibrosis in patients with non‐alcoholic fatty liver disease
S Petta, S Ciminnisi, V Di Marco, D Cabibi, C Cammà, A Licata, ...
Alimentary pharmacology & therapeutics 45 (4), 510-518, 2017
Mandaatit: Government of Italy
Arvostele
The UCP2 ‐866 G>A promoter region polymorphism is associated with nonalcoholic steatohepatitis.
R Fares, S Petta, R Lombardi, S Grimaudo, P Dongiovanni, R Pipitone, ...
Liver International 35 (5), 1574-1580, 2015
Mandaatit: Government of Italy
Arvostele
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
VC Di Maio, V Cento, M Aragri, S Paolucci, T Pollicino, N Coppola, ...
Journal of hepatology 68 (3), 597-600, 2018
Mandaatit: Government of Italy
Arvostele
PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD
S Grimaudo, S Bartesaghi, R Rametta, F Marra, R Margherita Mancina, ...
Liver International 41 (2), 321-332, 2021
Mandaatit: Knut and Alice Wallenberg Foundation, Swedish Research Council, European …
Arvostele
Viral resistance in HCV infection
F Ceccherini-Silberstein, V Cento, VC Di Maio, CF Perno, A Craxì
Current opinion in virology 32, 115-127, 2018
Mandaatit: Government of Italy
Arvostele
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C
VC Di Maio, S Barbaliscia, E Teti, G Fiorentino, M Milana, S Paolucci, ...
Liver International 41 (8), 1802-1814, 2021
Mandaatit: Government of Italy
Saatavilla jossain: 67
Arvostele
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
Mandaatit: UK Medical Research Council
Arvostele
Elafibranor, an agonist of the peroxisome proliferator− activated receptor− α and− δ, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening
V Ratziu, SA Harrison, S Francque, P Bedossa, P Lehert, L Serfaty, ...
Gastroenterology 150 (5), 1147-1159. e5, 2016
Mandaatit: US National Institutes of Health
Arvostele
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: subanalyses of a phase III trial
J Bruix, JL Raoul, M Sherman, V Mazzaferro, L Bolondi, A Craxi, PR Galle, ...
Journal of hepatology 57 (4), 821-829, 2012
Mandaatit: US National Institutes of Health, Government of Spain
Arvostele
A randomized, placebo‐controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
SL Friedman, V Ratziu, SA Harrison, MF Abdelmalek, GP Aithal, ...
Hepatology 67 (5), 1754-1767, 2018
Mandaatit: US National Institutes of Health, UK Medical Research Council
Arvostele
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent
RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ...
Gastroenterology 150 (5), 1219-1230. e6, 2016
Mandaatit: US National Institutes of Health, Swedish Research Council
Arvostele
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ...
Hepatology 61 (2), 506-514, 2015
Mandaatit: Suomen Akatemiaa, Swedish Research Council, Government of Italy
Arvostele
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
Mandaatit: UK Medical Research Council
Arvostele
Statin use and non-alcoholic steatohepatitis in at risk individuals
P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ...
Journal of hepatology 63 (3), 705-712, 2015
Mandaatit: Suomen Akatemiaa, Swedish Research Council, Government of Italy
Arvostele
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
P Dongiovanni, S Stender, A Pietrelli, RM Mancina, A Cespiati, S Petta, ...
Journal of internal medicine 283 (4), 356-370, 2018
Mandaatit: US National Institutes of Health, Danish Council for Independent Research …
Arvostele
Lean NAFLD: a distinct entity shaped by differential metabolic adaptation
F Chen, S Esmaili, GB Rogers, E Bugianesi, S Petta, G Marchesini, ...
Hepatology 71 (4), 1213-1227, 2020
Mandaatit: National Health and Medical Research Council, Australia
Arvostele
Overexpression of interleukin‐23, but not interleukin‐17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis
F Ciccia, M Bombardieri, A Principato, AR Giardina, C Tripodo, R Porcasi, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2009
Mandaatit: Versus Arthritis, UK
Arvostele
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
B Donati, P Dongiovanni, S Romeo, M Meroni, M McCain, L Miele, S Petta, ...
Scientific reports 7 (1), 4492, 2017
Mandaatit: National Institute for Health Research, UK, European Commission, Government …
Arvostele
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
S Petta, M Maida, FS Macaluso, V Di Marco, C Cammà, D Cabibi, A Craxì
Hepatology 62 (4), 1101-1110, 2015
Mandaatit: Government of Italy
Arvostele
Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: association with the severity of liver disease
S Petta, C Argano, D Colomba, C Cammà, V Di Marco, D Cabibi, ...
Journal of hepatology 62 (4), 928-933, 2015
Mandaatit: Government of Italy
Tietokoneohjelma arvioi ja määrittää julkaisu- ja rahoitustiedot automaattisesti